FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/08/2025
Back to search
Official data from USPTO
ADVAXIA BIOLOGICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/08/2025
Trademark type
Combined
Nice classes
5, 42
Filing date
02/14/2023
Registration date
08/27/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2024
Last transaction
03/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
16
Owner location
IT
Examiner
BROWN, TINA
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "ADVAXIA" in dark purple, medium purple and light purple stylized font above the word "BIOLOGICS" in light purple stylized font.
Holders and representatives
Holders
Advaxia Biologics S.r.l.
Representatives
Larry H. Tronco Holland & Hart, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines
Class 42
Scientific and technological services and research and design relating theretoscientific researchproduct design and development in the field of biotherapeuticsdesign and testing for new product development; industrial analysis servicesbiotherapeutics manufacturing process developmentmaterial testingproduct testingproduct quality control testing and industrial research services in the field of biotherapeutics; design and development of computer hardware and software; biopharmaceutical product research and development for the pharmaceutical industry; research and development of vaccines and medicines; medical research; scientific research; scientific research in the pharmaceutical field; scientific research relating to bacteriology; scientific research relating to biology
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/14/2025
FIMP
FINAL DISPOSITION PROCESSED
02/14/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/24/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/28/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/27/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2024
PUBO
PUBLISHED FOR OPPOSITION
06/11/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/22/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/08/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/07/2024
GNFR
FINAL REFUSAL E-MAILED
02/07/2024
CNFR
FINAL REFUSAL WRITTEN
02/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2024
RFNT
REFUSAL PROCESSED BY IB
12/12/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/17/2023
RFRR
REFUSAL PROCESSED BY MPU
11/17/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/16/2023
CNRT
NON-FINAL ACTION WRITTEN
11/15/2023
DOCK
ASSIGNED TO EXAMINER
11/14/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/14/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/10/2023
Continuous trademark protection
Get notified about every new filing that threatens ADVAXIA BIOLOGICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.